A Trial of Vertebroplasty for Painful Chronic Osteoporotic Vertebral Fractures (Vertos V)

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 3, 2020

Study Completion Date

September 3, 2020

Conditions
OsteoporosisVertebral Fracture
Interventions
DEVICE

percutaneous vertebroplasty

Using fluoroscopic guidance, the practitioner infiltrates the skin and subcutaneous tissues overlying the pedicle of the target vertebra or vertebrae with 1% lidocaine and infiltrates the periosteum of the pedicles with 0.25% bupivacaine (marcaine. For the vertebroplasty procedure, 11-gauge or 13-gauge needles are passed into the central aspect of the target vertebra or vertebrae. Bone cement is prepared on the bench and injected under constant fluoroscopy into the vertebral body. Injection is stopped when the PMMA reaches the posterior aspect of the vertebral body or leaks into an extraosseous space, such as the intervertebral disk or an epidural or paravertebral vein.

PROCEDURE

Sham procedure

Using fluoroscopic guidance, the practitioner infiltrates the skin and subcutaneous tissues overlying the pedicle of the target vertebra or vertebrae with 1% lidocaine and infiltrates the periosteum of the pedicles with 0.25% bupivacaine (marcaine). During the sham intervention, verbal and physical cues, such as pressure on the patient's back, are given, and the methacrylate monomer (PMMA) is opened to simulate the odor associated with mixing of cement, but the needle is not placed and cement is not injected.

Trial Locations (1)

5022 GC

Elisabeth Tweesteden Ziekenhuis, Tilburg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Stryker Medical

INDUSTRY

collaborator

Medtronic

INDUSTRY

lead

Elisabeth-TweeSteden Ziekenhuis

OTHER